Funding news
ARTAN Bio logo

ARTAN Bio Raises $1.0M Seed Round

Recently funded · $1.0M SeedHospitals and Health CareView source

Get the full ARTAN Bio company profile

Access contacts, investors, buying signals & more

Open in Dashboard

A new biotech venture aiming to tackle aging at a genetic level, ARTAN Bio, has closed a $1.0M Seed funding round. The startup is focused on developing engineered tRNAs, a specialized class of molecules designed to suppress specific mutations that are directly associated with the aging process.

This initial capital infusion underscores a growing interest in innovative approaches to age-related conditions, providing ARTAN Bio with resources to advance its foundational research.

From the source

Anthony · Jul 1, 2026

Excited to share that ARTAN Bio just closed a $1M seed round — to advance our suppressor tRNA platform from preclinical toward first-in-human studies.

This funding supports the IND-enabling work, manufacturing, and regulatory groundwork needed to bring mutation-specific medicine to patients. None of this happens without the ARTAN team — huge thanks to Michael Torres and Brian Bodemann for the work that got us here. https://lnkd.in/evEGfmFU

Unlock the full source

CEO quotes, investor details and growth metrics

Start free trial

Other recently funded companies

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
GRAIL logo

GRAIL

United States

$7.1B
4
Illumina logo

Illumina

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Seed rounds

Companies that recently closed a Seed round.